Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: Studying Behavior of Acanthamoeba to Develop Targeted Strategies for Preventing Acanthamoeba Keratitis
Published on: September 20, 2024
Toxic effects of selected proprietary dry eye drops on Acanthamoeba
Ines Sifaoui1,2, María Reyes-Batlle3, Atteneri López-Arencibia3
1Laboratoire Matériaux-Molécules et Applications, IPEST, B.P 51 2070, University of Carthage, La Marsa, Tunisia. ines.sifaoui@hotmail.com.
Abstract:
Amoebae of the genus Acanthamoeba are ubiquitous protists that have been isolated from many sources such as soils, water and the air. They are responsible for infections including fatal encephalitis and a severe keratitis in humans. To date, there is no satisfactorily effective therapeutic agent against this pathogen and the infections it causes are exacerbated by the existence of a resistant cyst stage produced by this amoeba. As dry eye syndrome is a risk factor for Acanthamoeba keratitis, we aimed to evaluate the anti-Acanthamoeba activity of a variety of proprietary eye drops intended to treat dry eye syndrome. From the nine eye drop formulations tested, "Systane Ultra" was determined to be the most active against all tested Acanthamoeba strains. During our investigations into the mode of action of Systane Ultra, we discovered that it decreases mitochondrial membrane potential and ATP levels, induces chromatin condensation, and increases the permeability of the plasma-membrane.
Insights
Systane Ultra eye drops show significant anti-Acanthamoeba activity, offering a potential treatment for Acanthamoeba keratitis. This study evaluated its effectiveness against the pathogen by examining its effects on amoebic cell functions.
Area of Science:
- Microbiology
- Ophthalmology
- Parasitology
Background:
- Amoebae of the genus Acanthamoeba are widespread environmental protists.
- Acanthamoeba infections cause severe human diseases like encephalitis and keratitis.
- Current treatments for Acanthamoeba infections are inadequate, partly due to the organism's resistant cyst stage.
Purpose of the Study:
- To assess the efficacy of various over-the-counter eye drops against Acanthamoeba.
- To identify potential therapeutic agents for Acanthamoeba keratitis, especially in dry eye syndrome patients.
Main Methods:
- Nine different proprietary eye drop formulations were tested for their anti-Acanthamoeba activity.
- Systane Ultra was identified as the most effective formulation.
- Mechanisms of action were investigated, including effects on mitochondrial membrane potential, ATP levels, chromatin condensation, and plasma membrane permeability.
Main Results:
- Systane Ultra demonstrated the highest activity against all tested Acanthamoeba strains.
- The eye drop was found to disrupt Acanthamoeba's mitochondrial function and ATP production.
- Systane Ultra also induced chromatin condensation and increased cell membrane permeability in Acanthamoeba.
Conclusions:
- Systane Ultra exhibits significant anti-Acanthamoeba properties.
- Its mode of action involves compromising essential cellular functions of the amoeba.
- This finding suggests Systane Ultra as a promising candidate for managing Acanthamoeba keratitis, particularly in individuals with dry eye syndrome.
More Related Videos
Related Concept Videos
Frequency-dependent Selection
Dry Friction
To illustrate this concept, imagine a wooden crate resting on a rough, non-uniform horizontal surface. When an external force is applied to...
Drying Shrinkage
A portion of this drying shrinkage can be reversed; if the concrete is...
Excess Pressure Inside a Drop and a Bubble
What is Natural Selection?
Antibiotic Selection

